Literature DB >> 25013538

Neuromodulator threading: revisiting an approach to neurotoxin delivery.

H William Higgins1, Kachiu C Lee1, Yoash Enzer2.   

Abstract

Neuromodulator toxins are traditionally delivered to facial muscles via a depot technique using a 32g needle. This article revisits the threading technique, which was used more commonly in the 1990s and early 2000s prior to the introduction of the 32g x ½" gamma ray sterilized needle. A description of the threading technique, illustrated by diagrams and patient photos, is presented for the orbicularis oris and corrugator supercilii injection sites. In contrast to the depot technique in which the needle enters the skin at a 90-degree angle, the threading technique enters the skin at a 20- to 30-degree angle. Specifically, for the orbicularis oris, onabotulinum toxin A injections are performed 2 to 5mm beyond the "white roll" of the vermillion border. After the needle punctures the skin, the toxin is injected while withdrawing in a threading manner parallel to the vermillion border. This method is repeated along the entire length of the orbicularis oris muscle. For the corrugator supercilii muscles, the injection technique differs slightly. A depot injection is given at the most medial point of the muscle, targeting the body of the muscle. The tail of the corrugator supercilii is injected using the threading technique as described for the orbicularis oris, in which the needle inserts at a 20- to 30-degree angle. This paper revisits the threading injection technique for neurotoxin treatment of the orbicularis and corrugator supercilii sites.

Entities:  

Year:  2014        PMID: 25013538      PMCID: PMC4086532     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  15 in total

1.  Effect of volume and concentration on the diffusion of botulinum exotoxin A.

Authors:  T S Jeffrey Hsu; Jeffrey S Dover; Kenneth A Arndt
Journal:  Arch Dermatol       Date:  2004-11

2.  Comparison of the spread of three botulinum toxin type A preparations.

Authors:  Martina Kerscher; Susanna Roll; Andreas Becker; Walter Wigger-Alberti
Journal:  Arch Dermatol Res       Date:  2011-10-15       Impact factor: 3.017

3.  OnabotulinumtoxinA dose-ranging study for hyperdynamic perioral lines.

Authors:  Joel L Cohen; Steven H Dayan; Sue Ellen Cox; Ramana Yalamanchili; Greg Tardie
Journal:  Dermatol Surg       Date:  2012-05-23       Impact factor: 3.398

4.  Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?

Authors:  Alastair Carruthers; Jean Carruthers; Joel Cohen
Journal:  Dermatol Surg       Date:  2007-01       Impact factor: 3.398

5.  A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.

Authors:  Alastair Carruthers; Melissa Bogle; Jean D A Carruthers; Jeffrey S Dover; Kenneth A Arndt; Te-Shao Hsu; Jude Poirier
Journal:  Dermatol Surg       Date:  2007-05       Impact factor: 3.398

Review 6.  Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications.

Authors:  Ada Trindade de Almeida; Koenraad De Boulle
Journal:  J Cosmet Laser Ther       Date:  2007       Impact factor: 2.247

Review 7.  The five D's of botulinum toxin: doses, dilution, diffusion, duration and dogma.

Authors:  Ana Paula de Sa Earp; Ellen S Marmur
Journal:  J Cosmet Laser Ther       Date:  2008-06       Impact factor: 2.247

8.  Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.

Authors:  Alastair Carruthers; Jean Carruthers
Journal:  Dermatol Surg       Date:  2005-10       Impact factor: 3.398

9.  Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg.

Authors:  Luca Carli; Cesare Montecucco; Ornella Rossetto
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

10.  Botulinum toxin A treatment of perioral rhytides.

Authors:  Natalie Semchyshyn; Roberta D Sengelmann
Journal:  Dermatol Surg       Date:  2003-05       Impact factor: 3.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.